These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics. Ala-Korpela M, Sipola P, Kaski K. Ann Med; 2006 Sep; 38(5):322-36. PubMed ID: 16938802 [Abstract] [Full Text] [Related]
10. Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis. Mulder WJ, Strijkers GJ, Vucic E, Cormode DP, Nicolay K, Fayad ZA. Top Magn Reson Imaging; 2007 Oct 01; 18(5):409-17. PubMed ID: 18025995 [Abstract] [Full Text] [Related]
11. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice. Yasuda S, Ikuta K, Uwatoku T, Oi K, Abe K, Hyodo F, Yoshimitsu K, Sugimura K, Utsumi H, Katayama Y, Shimokawa H. J Vasc Res; 2008 Oct 01; 45(2):123-8. PubMed ID: 17940339 [Abstract] [Full Text] [Related]
12. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. Wilensky RL, Song HK, Ferrari VA. J Am Coll Cardiol; 2006 Apr 18; 47(8 Suppl):C48-56. PubMed ID: 16631510 [Abstract] [Full Text] [Related]